Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes

作者: Nigel J.M. Birdsall , Tim Farries , Parviz Gharagozloo , Shinsaku Kobayashi , Donald Kuonen

DOI: 10.1016/S0024-3205(97)00046-5

关键词: Muscarinic acetylcholine receptorMuscarinic acetylcholine receptor M2Acetylcholine bindingMuscarinic acetylcholine receptor M1BiophysicsMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptor M4Muscarinic acetylcholine receptor M3AcetylcholineChemistryBiochemistry

摘要: The ternary allosteric model predicts the possibility of discovering molecules with novel and highly subtype-selective modes action. This approach has been applied to muscarinic receptors. alkaloid brucine is capable selectively enhancing by an mechanism effects low but not high concentrations acetylcholine at only m1 subtype A simple derivative brucine, N-chloromethylbrucine, enhances actions m3 In addition it binds to, does affect, properties m4 receptors, thereby demonstrating neutral cooperativity 'absolute' selectivity action receptors over Brucine N-oxide binding m5 These findings allow developing agents that have a targeted mode action; they may act on single receptor which functioning sub-optimally therefore be use therapeutically in early stages Alzheimer's Disease.

参考文章(28)
Alan P. Kozikowski, Drug design for neuroscience Raven Press. ,(1993)
E. C. Hulme, Nigel J. M. Birdsall, Receptor biochemistry : a practical approach IRL Press at Oxford University Press. ,(1990)
J Proska, S Tucek, Competition between positive and negative allosteric effectors on muscarinic receptors. Molecular Pharmacology. ,vol. 48, pp. 696- 702 ,(1995)
Günter Lambrecht, Ulrich Moser, Ulrike Grimm, Otmar Pfaff, Ulrike Hermanni, Caren Hildebrandt, Magali Waelbroeck, Jean Christophe, Ernst Mutschler, New functionally selective muscarinic agonists Life Sciences. ,vol. 52, pp. 481- 488 ,(1993) , 10.1016/0024-3205(93)90305-M
J. Jaen, S. Barrett, M. Brann, M. Callahan, R. Davis, P. Doyle, D. Eubanks, D. Lauffer, L. Lauffer, W. Lipinski, D. Moreland, C. Nelson, C. Raby, R. Schwarz, C. Spencer, H. Tecle, In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832. Life Sciences. ,vol. 56, pp. 845- 852 ,(1995) , 10.1016/0024-3205(95)00019-3
S. Tuček, J. Proška, Allosteric modulation of muscarinic acetylcholine receptors Trends in Pharmacological Sciences. ,vol. 16, pp. 205- 212 ,(1995) , 10.1016/S0165-6147(00)89023-9
R. Bartus, R. Dean, B Beer, A. Lippa, The cholinergic hypothesis of geriatric memory dysfunction Science. ,vol. 217, pp. 408- 414 ,(1982) , 10.1126/SCIENCE.7046051
E K Perry, B E Tomlinson, G Blessed, K Bergmann, P H Gibson, R H Perry, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia BMJ. ,vol. 2, pp. 1457- 1459 ,(1978) , 10.1136/BMJ.2.6150.1457
Waclaw S. Adamus, Joachim P. Leonard, Wolfgang Tröger, Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease. Life Sciences. ,vol. 56, pp. 883- 890 ,(1995) , 10.1016/0024-3205(95)00024-Z